SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-18.78%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$261M
AUM Growth
+$26.1M
(+11%)
Cap. Flow
+$62.9M
Cap. Flow
% of AUM
24.14%
Top 10 Holdings %
Top 10 Hldgs %
37.23%
Holding
89
New
29
Increased
20
Reduced
14
Closed
14
Top Buys
| 1 |
Cencora
COR
|
$9.97M |
| 2 |
CVS Health
CVS
|
$9.49M |
| 3 |
Medtronic
MDT
|
$8.72M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$8.2M |
| 5 |
Novo Nordisk
NVO
|
$6.79M |
Top Sells
| 1 |
GSK
GSK
|
$14.6M |
| 2 |
AET
Aetna Inc
AET
|
$12.3M |
| 3 |
Kura Oncology
KURA
|
$8.19M |
| 4 |
Biogen
BIIB
|
$6.82M |
| 5 |
Elevance Health
ELV
|
$6.8M |
Sector Composition
| 1 | Healthcare | 95.45% |
| 2 | Technology | 0.48% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOGC
51
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $1.65M | 0.6% |
+158,958
| New | +$1.65M |
|
52
Inogen
INGN
$215M
| $1.59M | 0.58% |
+12,824
| New | +$1.59M |
|
|
CBAY
53
DELISTED
Cymabay Therapeutics
CBAY
| $1.47M | 0.54% |
+187,327
| New | +$1.47M |
|
54
Establishment Labs
ESTA
$1.11B
| $1.45M | 0.53% |
52,701
+8,023
| +18% | +$220K |
|
55
Senseonics Holdings
SENS
$384M
| $1.24M | 0.45% |
479,858
+77,450
| +19% | +$201K |
|
56
Axsome Therapeutics
AXSM
$6.1B
| $1.07M | 0.39% |
380,812
-35,646
| -9% | -$101K |
|
|
IVC
57
DELISTED
Invacare Corporation
IVC
| $1.06M | 0.39% |
+247,196
| New | +$1.06M |
|
58
Veracyte
VCYT
$2.4B
| $883K | 0.32% |
+70,199
| New | +$883K |
|
59
Achieve Life Sciences
ACHV
$144M
| $723K | 0.26% |
29,869
+21,570
| +260% | +$522K |
|
|
PFNX
60
DELISTED
Pfenex Inc.
PFNX
| $681K | 0.25% |
213,608
| – | – |
|
|
TMDI
61
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
| $544K | 0.2% |
445,680
| – | – |
|
|
AFMD
62
DELISTED
Affimed
AFMD
| $503K | 0.18% |
16,164
-39,598
| -71% | -$1.23M |
|
|
CFMS
63
DELISTED
Conformis, Inc. Common Stock
CFMS
| $402K | 0.15% |
44,876
-29,596
| -40% | -$265K |
|
|
IMMU
64
DELISTED
Immunomedics Inc
IMMU
| $370K | 0.13% |
+25,900
| New | +$370K |
|
65
Actinium Pharmaceuticals
ATNM
$52.7M
| $132K | 0.05% |
+11,327
| New | +$132K |
|
|
OPTN
66
DELISTED
OptiNose
OPTN
| – | – |
-1,805
| Closed | -$336K |
|
67
Arbutus Biopharma
ABUS
$755M
| – | – |
-164,943
| Closed | -$1.56M |
|
68
Arrowhead Research
ARWR
$3.93B
| – | – |
-114,259
| Closed | -$2.19M |
|
69
AstraZeneca
AZN
$255B
| – | – |
0
| – | – |
|
|
70
Biogen
BIIB
$20.5B
| – | – |
-19,300
| Closed | -$6.82M |
|
71
electroCore
ECOR
$38.1M
| – | – |
-5,747
| Closed | -$1.21M |
|
|
72
Elevance Health
ELV
$70.4B
| – | – |
-24,803
| Closed | -$6.8M |
|
|
73
GSK
GSK
$79.6B
| – | – |
-291,168
| Closed | -$14.6M |
|
74
Immunic
IMUX
$76M
| – | – |
-2,593
| Closed | -$29K |
|
75
Lexicon Pharmaceuticals
LXRX
$378M
| – | – |
0
| – | – |
|